18F-FDG PET/CT of transitional cell carcinoma.
OBJECTIVE
The objective of this article is to provide a practical illustrated review of PET/CT in the imaging evaluation of transitional cell carcinoma.


CONCLUSIONS
Local evaluation of the primary tumor in patients with transitional cell carcinoma on PET is often limited by the obscuring effect of excreted FDG, but assessment of metabolic activity may still be possible through close correlation with CT images. PET/CT may also be helpful in the detection of disease outside the bladder at nodal or more distant sites and in the assessment of recurrent disease.
Patil
Vivek V
VV
Department of Radiology, University of California San Francisco, San Francisco, CA 94143-0628, USA.
Wang
Zhen J
ZJ
Sollitto
Richard A
RA
Chuang
Kai-Wen
KW
Konety
Badrinath R
BR
Hawkins
Randy A
RA
Coakley
Fergus V
FV
D002295:Carcinoma, Transitional Cell / Q000000981:diagnostic imaging* / Q000473:pathology; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000473:pathology; D009367:Neoplasm Staging / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18